Sharps Technology IncNASDAQ:STSSNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.2912
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.2912
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STSS |
|---|---|---|
| 09:32 ET | 617 | 0.286 |
| 10:06 ET | 400 | 0.2874 |
| 10:10 ET | 1100 | 0.2874 |
| 10:12 ET | 300 | 0.29 |
| 10:17 ET | 235 | 0.29 |
| 10:19 ET | 203 | 0.29 |
| 10:39 ET | 142 | 0.2872 |
| 10:48 ET | 505 | 0.2872 |
| 11:02 ET | 100 | 0.2899 |
| 11:18 ET | 100 | 0.2899 |
| 11:20 ET | 200 | 0.2898 |
| 11:22 ET | 1785 | 0.2896 |
| 11:31 ET | 300 | 0.2898 |
| 11:33 ET | 300 | 0.2895 |
| 11:36 ET | 4443 | 0.2876 |
| 11:40 ET | 3989 | 0.2819 |
| 11:42 ET | 300 | 0.2801 |
| 11:49 ET | 300 | 0.2801 |
| 12:20 ET | 100 | 0.2892 |
| 03:59 ET | 612 | 0.2912 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sharps Technology Inc | 4.6M | -0.4x | --- |
Dror Ortho-Design Inc | 4.3M | -1.0x | --- |
Nu-Med Plus Inc | 5.6M | -43.5x | --- |
Arch Therapeutics Inc | 5.6M | -0.3x | --- |
Accustem Sciences Inc | 3.4M | -1.6x | --- |
Reflect Scientific Inc | 4.6M | -9.9x | --- |
Company Information
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Contact Information
- Headquarters
- 105 Maxess Road, Ste. 124MELVILLE, NY, United States 11747
- Phone
- 516-246-4000
- Fax
- ---
Executives
- Independent Chairman of the Board
- Soren Christiansen
- Chief Executive Officer, Director
- Robert Hayes
- Chief Financial Officer
- Andrew Crescenzo
- Independent Director
- Paul Danner
- Independent Director
- Jason Monroe
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 15.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.76 |
Book Value | $0.52 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
